Comparison

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

 

Click on the organs and learn more about cancer types

´

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

2719 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Glembatumumab Vedotin Biosimilar -­ Research Grade Hu FA CHO cells ICH5575V-0.1mg

IchorBio
0.1 mg Login
Compare
Glembatumumab Vedotin Biosimilar -­ Research Grade Hu FA CHO cells ICH5575V-1mg

IchorBio
1 mg Login
Compare
Grisnilimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5584-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Grisnilimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5584-1mg

IchorBio
1 mg Login
Compare
Grisnilimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5584-25mg

IchorBio
25 mg Login
Compare
Grisnilimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5584-50mg

IchorBio
50 mg Login
Compare
Grisnilimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5584-5mg

IchorBio
5 mg Login
Compare
Icrucumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5589-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Icrucumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5589-1mg

IchorBio
1 mg Login
Compare
Icrucumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5589-25mg

IchorBio
25 mg Login
Compare
Icrucumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5589-50mg

IchorBio
50 mg Login
Compare
Icrucumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5589-5mg

IchorBio
5 mg Login
Compare
Ifabotuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5591-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Ifabotuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5591-1mg

IchorBio
1 mg Login
Compare
Ifabotuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5591-25mg

IchorBio
25 mg Login
Compare
Ifabotuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5591-50mg

IchorBio
50 mg Login
Compare
Ifabotuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5591-5mg

IchorBio
5 mg Login
Compare
Igovomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5592-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Igovomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5592-1mg

IchorBio
1 mg Login
Compare
Igovomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5592-25mg

IchorBio
25 mg Login
Compare
Igovomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5592-50mg

IchorBio
50 mg Login
Compare
Igovomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5592-5mg

IchorBio
5 mg Login
Compare
Iladatuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5593-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Iladatuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5593-1mg

IchorBio
1 mg Login
Compare
Iladatuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5593-25mg

IchorBio
25 mg Login
Compare
Name Price
Glembatumumab Vedotin Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 0.1 mg
Available
Glembatumumab Vedotin Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Grisnilimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Grisnilimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Grisnilimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Grisnilimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Grisnilimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Icrucumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Icrucumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Icrucumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Icrucumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Icrucumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Ifabotuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Ifabotuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Ifabotuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Ifabotuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Ifabotuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Igovomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Igovomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Igovomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Igovomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Igovomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Iladatuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Iladatuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Iladatuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available

2719 Item(s)

per page